Details of the Drug | DrugMAP

General Information of Drug (ID: DME8HA3)

Drug Name

BAY 87-2243

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C26H26F3N7O2
Canonical SMILES: CC1=CC(=NN1CC2=CC(=NC=C2)N3CCN(CC3)C4CC4)C5=NC(=NO5)C6=CC=C(C=C6)OC(F)(F)F
InChI: 1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3
InChIKey: CDJNNOJINJAXPV-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 67377767
CAS Number: 1227158-85-1
TTD ID: D0F3RQ

References

1	ClinicalTrials.gov (NCT01297530) Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies. U.S. National Institutes of Health.